Treatment of Hantavirus Pulmonary Syndrome

Abstract

Viruses in the genus Hantavirus can cause one of two illnesses when transmitted from rodents to humans: hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syndrome (HPS). Of the two diseases, HPS is more severe with an approximate 40% mortality across the Americas. The high rate of mortality could be reduced if effective therapeutics could be discovered for treatment of this illness. Herein we review approaches being explored for the discovery of therapeutics for HPS and how they could be employed in treatment and prevention of disease.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 14, 2007
Accession Number
ADA486103

Entities

People

  • Colleen B. Jonsson
  • Gregory Mertz
  • Jay W. Hooper

Organizations

  • United States Army Medical Research Institute of Infectious Diseases

Tags

DTIC Thesaurus Topics

  • Blood
  • Bunyaviridae Infections
  • Cells
  • Health Services
  • Infectious Diseases
  • Medical Personnel
  • Pain
  • Proteins
  • Therapy
  • United States
  • Viruses

Fields of Study

  • Medicine

Readers

  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Virology (or Medical Virology).